Literature DB >> 22158590

Antioxidant, anti-glycation and anti-inflammatory activities of phenolic constituents from Cordia sinensis.

Nawal Al-Musayeib1, Shagufta Perveen, Itrat Fatima, Muhammad Nasir, Ajaz Hussain.   

Abstract

Nine compounds have been isolated from the ethyl acetate soluble fraction of C. sinensis, namely protocatechuic acid (1), trans-caffeic acid (2), methyl rosmarinate (3), rosmarinic acid (4), kaempferide-3-O-β-D-glucopyranoside (5), kaempferol-3-O-β-D-glucopyranoside (6), quercetin-3-O-β-D-glucopyranoside (7), kaempferide-3-O-α-L-rhamnopyranosyl (1→6)-β-D-glucopyranoside (8) and kaempferol-3-O-α-L-rhamno-pyranosyl (1→6)-β-D-glucopyranoside (9), all reported for the first time from this species. The structures of these compounds were deduced on the basis of spectroscopic studies, including 1D and 2D NMR techniques. Compounds 1-9 were investigated for biological activity and showed significant anti-inflammatory activity in the carrageen induced rat paw edema test. The antioxidant activities of isolated compounds 1-9 were evaluated by the DPPH radical scavenging test, and compounds 1, 2, 4 and 7-9 exhibited marked scavenging activity compared to the standard BHA. These compounds were further studied for their anti-glycation properties and some compounds showed significant anti-glycation inhibitory activity. The purity of compounds 2-5, 8 and 9 was confirmed by HPLC. The implications of these results for the chemotaxonomic studies of the genus Cordia have also been discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22158590      PMCID: PMC6264710          DOI: 10.3390/molecules161210214

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


1. Introduction

The genus Cordia belongs to the family Boraginaceae, with some 300 species distributed worldwide, mostly in the warmer regions of the World [1]. According to a literature survey, several uses in traditional medicine have been reported for different Cordia species [2,3,4,5,6]. The ethnopharmacological and chemotaxonomic importance of the genus Cordia led us to investigate the chemical constituents of one of its species, namely Cordia sinensis, which is a medicinal plant found widespread in the drier parts of Saudi Arabia, Africa and India [7]. The bark of C. sinensis is used for stomach disorders and for chest pains [8]. A literature survey revealed that very little phytochemical work has so far been carried out on C. sinensis. A methanolic extract of this plant showed strong toxicity in the brine shrimp lethality test and on subsequent fractionation, the major toxicity was observed in the ethyl acetate soluble sub-fraction. Further pharmacological screening of this fraction revealed potent antioxidant activity. In this paper we report the isolation of nine known compounds isolated for the first time from this plant: protocatechuic acid (1) [9], trans-caffeic acid (2) [10], methyl rosmarinate (3) [11], rosmarinic acid (4) [11], kaempferide-3-O-β-D-glucopyranoside (5) [12], kaempferol-3-O-β-D-glucopyranoside (6) [13], quercetin-3-O-β-D-glucopyranoside (7) [14], kaempferide-3-O-α-L-rhamnopyranosyl (1→6)-β-D-glucopyranoside (8) [13] and kaempferol-3-O-α-L-rhamnopyranosyl (1→6)-β-D-glucopyranoside (9) [13] (Figure 1). This study was undertaken to investigate the antioxidant potential of these compounds using the 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activity assay. In vivo anti-inflammatory activity for all of the compounds was also determined by the carrageen induced rat paw edema test. Finally, these compounds were studied for their anti-glycation properties. The purity of compounds 2–5, 8 and 9 was also confirmed by analytical HPLC.
Figure 1

Structures of compounds 1–9.

2. Results and Discussion

2.1. Compounds and Their Biological Activities

The MeOH extract of the aerial part of C. sinensis was divided into different sub-fractions soluble in n-hexane, EtOAc and n-BuOH. The EtOAc soluble sub-fraction was subjected to a series of column chromatography fractionations to afford compounds 1–9. Their structures were established by MS spectrometry, UV, IR as well as NMR spectroscopy and comparison with literature data. The antioxidant activity of compounds 1–9 was measured by the 1,1-diphenyl-2-picrylhydrazyl (DPPH) method and the results are summarized in Table 1. Compounds 1–4, 7–9 showed significant free radical scavenging activity in this assay. Among these, rosmarinic acid (4), protocatechuic acid (1), trans-caffeic acid (2) and quercetin-3-O-β-D-glucopyranoside (7) were found to have high antioxidant potentials, with IC50 = 13.5, 14.1, 16.3 and 19.1 µM, respectively, compared to the standard BHA (IC50 = 44.3 µM). The antioxidant activity of flavonoids depends upon the arrangement of functional groups about the nuclear structure [15]. Accordingly, the ortho-dihydroxy (catechol) structure in compounds 1, 2, 4 plays an important role in their antioxidative function as in flavonoid 7, and this can further explain the weak scavenging activity (IC50 = 53.4 µM) of kaempferol-3-O-β-D-glucopyranoside (6) which lacks the B-ring catechol system [16]. On the other hand, the reduced antioxidant activity of kaempferide-3-O-β-D-glucopyranoside (5) (IC50 = 55.5 µM) could be attributed to 4'-O-methylation that perturbs ring planarity through steric effects. The antioxidant activities of kaempferol-3-O-α-L-rhamnopyranosyl (1→6)-β-D-glucopyranoside 9 (IC50 = 39.5 µM) and kaempferide-3-O-α-L-rhamnopyranosyl (1→6)-β-D-glucopyranoside 8 (IC50 = 42.4 µM), were comparable to that of BHA [17].
Table 1

IC50 (µM) values of compounds 1–9 in the DPPH antioxidant assay.

CompoundsDPPH Scavenging Activity IC50a [μM]
1 16.3 ± 0.19
2 14.1 ± 0.14
3 22.7 ± 0.17
4 13.5 ± 0.21
5 55.5 ± 0.12
6 53.4 ± 0.88
7 19.1 ± 0.90
8 42.4 ± 0.91
9 39.5 ± 0.85
BHAb 44.3 ± 0.09

a Values ± SEM (standard mean error of three assays); b Standard DPPH scavenging activity.

Structures of compounds 1–9. IC50 (µM) values of compounds 1–9 in the DPPH antioxidant assay. a Values ± SEM (standard mean error of three assays); b Standard DPPH scavenging activity. The oxidation process is believed to play an important role in advanced glycation as endproducts (AGEs) formation [18]. On the basis of a literature search, several natural phenolic compounds known to possess antioxidative properties, such as curcumin, rutin, garcinol and arbutin have been found to have strong antiglycation activity [19,20]. We report here for the first time the anti-glycation properties of the plant phenolics 1–9, obtained from C. sinensis (Table 2).
Table 2

Anti-glycation activity of compounds 1–9.

Compounds% Inhibition
168.0
269.2
388.4
487.3
576.5
674.0
771.2
880.7
979.0
Rutin a86.0

a Used as Standard.

Anti-glycation activity of compounds 1–9. a Used as Standard. Moreover, evaluation of the anti-inflammatory potential of the isolated compounds on carrageen-induced rat paw edema showed significant the potent anti-inflammatory activity of compounds 5 and 6 (62.4% and 59.6%, respectively). These flavonol glycosides were evidently more active than diclofenac sodium, which showed 57.6% inhibition of carrageen-induced rat paw edema, while compound 1 (55.0%) showed an effect comparable to that of the reference compound. The other tested compounds 2, 7, 8 and 9 displayed lower percentages of inhibition in the 38.4–51.2% range and were therefore less active than diclofenac sodium in this assay (Table 3) [21].
Table 3

Anti-inflammatory potential of compounds 1–9 in carrageen induced paw edema of rats.

Group (3 rats in each)Treatment 100 mg/kgEdema Volume (Vc = Vf − V0)Percent Inhibition (%)
1Cage-1 control0
2Diclofenac Sodium0.22 ± 0.0557.6
310.23 ± 0.0455.0
420.26 ± 0.1950.0
53--
64--
750.24 ± 0.1362.4
860.21 ± 0.1159.6
970.25 ± 0.0851.2
1080.35 ± 0.2143.5
1190.32 ± 0.0738.4
Anti-inflammatory potential of compounds 1–9 in carrageen induced paw edema of rats.

2.2. Chemotaxonomic Significance

The genus Cordia is known for the presence of a variety of secondary metabolites. Previous investigations led to the isolation of cytotoxic monoterpenes from the roots of C. curassavica and C. globosa [3,4], meroterpenoid naphthoquinones from the roots of C. linnaei [6], anti-inflammatory sesquiterpenes from C. trichotoma and C. verbenacea [5,22], abietane type diterpenes from C. latifolia [23], triterpenes from C. spinescens, C. multispicata and from C. verbenacea [24,25,26], saponins from C. piauhiensis [27,28,29],antifungal and larvicidal phenylpropanoid derivatives from the root bark of C. alliodora [2], essential oils from C. cylindrostachya [30], flavonoids from C. dichotoma, C. obliqua and from the flowers of C. dentate [31,32,33], flavonones from the aerial parts of C. glosbosa, C. oblique, C. francisci, C. martinicensis, C. myxa and C. serratifolia [34], pyrrolizidine alkaloids from C. myxa and glutarimide alkaloids from C. globifera [35,36], lignan from C. rufescens [37], rosmarinic acid from C. americana and different aromatic compounds from C. latifolia and C. dentate [38,39,40]. The present study reported the isolation of compounds 1–9 from the aerial parts of C. sinensis. This adds kaempferol type flavonoid glycosides 6–9 to the list of genus Cordia, while all of the other compounds were isolated for the first time from the plant C. sinensis. The isolation and identification of these compounds from C. sinensis represents a contribution to the phytochemical analysis of the components of the plant and it may be useful in further chemotaxonomic studies on the genus Cordia.

3. Experimental

3.1. General

The UV and IR spectra were recorded on Hitachi-UV-3200 and JASCO 320-A spectrometers, respectively. The 1H-, 13C-NMR and 2D-NMR spectra were recorded on a Bruker AMX-400 spectrometer with tetramethylsilane (TMS) as an internal standard. Chemical shifts are in given ppm (δ), relative to tetramethylsilane as an internal standard and scalar coupling constants (J) are reported in Hertz. FAB and HRFABMS (neg. ion mode, matrix: glycerol) were registered on a JEOL JMS-HX110 mass spectrometer. Thin layer chromatography (TLC) was performed on precoated silica gel F254 plates (E. Merck, Darmstadt, Germany); the detection was done at 254 nm and by spraying with ceric sulphate reagent. All chemicals were purchased from Sigma Chemical Company (St. Louis, MO, USA). Analytical HPLC was performed with Shimadzu HPLC equipment comprising an LC-10 ATVP pump, SPD-M.OA AVP photodiode-array (PDA) detector set at 271 nm, and a Rheodyne 7010 SIL-10 ADVP injector equipped with a 50-μL sample loop. Compounds were injected on a 250 mm × 4.0 mm, 5 μm particle size LiChrospher 100 RP-18 column from Merck (Darmstadt, Germany). The mobile phase was a 1:1 mixture of acetonitrile (ACN) and 0.05% aqueous trifluoroacetic acid at a flow rate of 1.0 mL min−1. Before use the mobile phase was filtered and degassed.

3.2. Plant Material

The whole plant of Cordia sinensis (Boraginaceae) was collected from Riyadh (Saudi Arabia) and identified by Dr. M. Atiqur Rahman, Plant Taxonomist, College of Pharmacy, King Saud University. A voucher specimen No.30 was deposited in the herbarium of the Department of Pharmacognosy, King Saud University, Riyadh, Saudi Arabia.

3.3. Extraction and Isolation

The shade dried plant material (1.5 kg) was extracted with methanol (6.0 L, thrice) at room temperature. The combined methanolic extract was evaporated under reduced pressure to give a thick gummy mass (70 g) that was suspended in water and successively extracted with n-hexane, ethyl acetate and n-butanol to afford the corresponding sub-fractions. The ethyl acetate soluble sub-fraction (15 g) was subjected to column chromatography eluting with CHCl3, CHCl3-MeOH and MeOH in increasing order of polarity to obtain five fractions I–V. Fraction I obtained from CHCl3-MeOH (9.9:0.1) was further purified by column chromatography eluting with CHCl3-MeOH (9.7:0.3) to afford compounds 1 (10 mg) and 2 (25 mg) from the top and the tail fractions, respectively. Fraction II obtained from CHCl3-MeOH (9.8:0.2) was a mixture of two components, which were separated by column chromatography using the solvent system CHCl3-MeOH (9.5:0.5) to afford compounds 3 (18 mg) and 4 (25 mg) from the top and the tail fractions, respectively. Fraction III obtained from CHCl3-MeOH (9.5:0.5) was further purified by Sephadex LH-20 column chromatography eluting with H2O-MeOH (8.0:2.0) to afford compounds 5 (19 mg) and 6 (10 mg). Fraction IV obtained from CHCl3-MeOH (9.3:0.7) was quite pure and rechromatography using the solvent system CHCl3-MeOH (9.0:1.0) gave compound 7 (11 mg). Fraction V obtained from CHCl3-MeOH (9.0:1.0) was further purified by Sephadex LH-20 column chromatography eluting with H2O-MeOH (8.5:1.5) to afford compounds 8 (20 mg) and 9 (20 mg). Compounds 1–9 were identified through comparison of their physical and spectral data with those reported in the literature. The absolute configuration of the sugar moieties in compounds 5–9 were determined by acid hydrolysis and the separated sugars were identified as L-rhamnose and D-glucose through co-TLC with authentic samples and the sign of the optical rotation [α]25D = +7.8 to +7.9 for L-rhamnose and [α]25D = +52.0 to +52.2 for D-glucose, respectively.

3.4. HPLC Analysis of the Purity of Compounds , and

Compounds 2–5, 8 and 9 (each 2.0 mg) was dissolved in Millipore water (HPLC grade, 5 mL) and the solution was filtered through a 0.45 μm Millipore filter. Compound 2 was detected at Rt 9.061 min, compound 3 was detected at Rt 20.569 min, compound 4 was detected at Rt 27.256 min, compound 5 was detected at Rt 22.542 min, compound 8 was detected at Rt 36.937 min, while compound 9 appeared at Rt 39.181 min (Figure 2). Compounds 1, 6 and 7 were not isolated in sufficient amounts, so the purity of these compounds was not checked by HPLC.
Figure 2

HPLC chromatograms of compounds 2–5, 8, 9.

HPLC chromatograms of compounds 2–5, 8, 9.

3.5. Spectral Data

Protocatechuic acid (1). White crystals; m.p. 199–201 °C; HREIMS: m/z = 154.0258 (calc. for C7H6O4, 154.0266). 1H-NMR (CD3OD, 500 MHz): δ 6.80 (d, 1H, J = 8.1 Hz, 5-H), 7.30 (dd, 1H, J = 2.0, 8.1 Hz, 6-H), 7.46 (d, 1H, J = 2.0 Hz, 2-H); 13C-NMR (CD3OD, 125 MHz): δ 167.5 (COOH), 150.1 (C-4), 145.0 (C-3), 122.0 (C-6), 121.8 (C-1), 116.7 (C-2), 115.3 (C-5). trans -Caffeic acid (2). White solid; m.p. 129–130 °C; HREIMS: m/z = 180.0391 (calc. for C9H8O4, 180.0423). 1H-NMR (CD3OD, 500 MHz): δ 7.51 (1H, d, J = 15.9 Hz, H-1°), 6.23 (1H, d, J = 15.9 Hz, H-2°), 7.14 (1H, d, J = 1.8 Hz, H-2), 7.02 (1H, dd, J = 1.8, 8.1 Hz, H-6), 6.85 (1H, d, J = 8.1 Hz, H-5); 13C-NMR (CD3OD, 125 MHz): δ 125.2 (C-1), 115.9 (C-2), 117.0 (C-5), 122.0 (C-6), 149.6 (C-4), 147.5 (C-3), 175.0 (C-1°), 123.5 (C-2°), 156.0 (C-3°). Methyl rosmarinate (3). Yellow amorphous powder; m.p. 164–166 °C; HRFABMS: m/z = 375.1072 (calc. for C19H19O8, 375.1080). 1H-NMR (CD3OD, 500 MHz): δ 7.55 (1H, d, J = 15.5 Hz, H-7'), 7.04 (1H, d, J = 2.0 Hz, H- 2'), 6.95 (H, dd, J = 8.5, 2.0 Hz, H-6'), 6.78 (1H, d, J = 8.5 Hz, H-5'), 6.70 (1H, d, J = 2.0 Hz, H-2), 6.69 (1H, d, J = 8.0 Hz, H-5), 6.57 (1H, dd, J = 8.0, 2.0 Hz, H-6), 6.26 (1H, d, J = 15.5 Hz, H-8'), 5.19 (1H, dd, J = 7.5, 5.0 Hz, H-8), 3.70 (3H, s, OCH3), 3.06 (1H, dd, J = 14.5, 5.5 Hz, H-7a), 3.00 (1H, dd, J = 14.5, 5.5 Hz, H-7b); 13C-NMR (CD3OD, 125 MHz): δ 172.34 (C-9), 168.50 (C-9'), 150.10 (C-4'), 148.14 (C-7'), 147.03 (C-3'), 146.37 (C-3), 145.55 (C-4), 128.89 (C-1), 127.67 (C-1'), 123.38 (C-6'), 121.92 (C-6), 117.67 (C-2), 116.66 (C-5'), 116.45 (C-5), 115.34 (C-2'), 114.23 (C-8'), 74.82 (C-8), 52.82 (OCH3), C-38.05 (C-7). Rosmarinic acid (4). Yellow amorphous powder; m.p. 172–174 °C; HRFABMS: m/z = 361.0875 (calc. for C18H17O8, 361.0923). 1H-NMR (CD3OD, 500 MHz): δ 7.51 (1H, d, J = 15.5 Hz, H-7'), 7.03 (1H, d, J = 2.0 Hz, H-2'), 6.91 (1H, dd, J = 8.0, 2.0 Hz, H-6'), 6.77 (1H, d, J = 8.0 Hz, H-5'), 6.72 (1H, d, J = 2.0 Hz, H-2), 6.68 (1H, d, J = 8.0 Hz, H-5), 6.63 (1H, dd, J = 8.0, 2.0 Hz, H-6), 6.27 (1H, d, J = 15.5 Hz, H-8'), 5.09 (1H, dd, J = 10.0, 3.5 Hz, H-8), 3.10 (1H, dd, J = 14.5, 3.5 Hz, H-7a), 2.94 (1H, dd, J = 14.5, 10.0 Hz, H-7b); 13C-NMR (CD3OD, 125 MHz): δ 177.64 (C-9), 169.24 (C-9'), 149.50 (C-4'), 146.85 (C- 3'), 146.79 (C-7'), 146.08 (C-3), 144.93 (C-4), 131.29 (C-1), 128.12 (C-1'), 123.04 (C-6'), 121.89 (C-6), 117.63 (C-2), 116.60 (C-5'), 116.34 (C-5), 115.77 (C-8'), 115.27 (C-2'), 77.79 (C-8), 38.93 (C-7). Kaempferide-3-O-β-D-glucopyranoside (5). Yellow amorphous powder; m.p. 165–167 °C; HRFABMS: m/z = 461.1072 (calc. for C22H21O11, 461.1084). 1H-NMR: δ (DMSO-d, 500 MHz,) 7.90 (2H, d, J = 8.4 Hz, H-2′, 6′), 6.87 (2H, d, J = 8.4 Hz, H-3′, 5′), 6.41 (1H, brs, H-8), 6.23 (1H, brs, H-6), 5.30 (1H, d, J = 7.5 Hz, H-1″), 3.2–4.3 (6H, sugar), 3.85 (3H, s, OCH3). 13C-NMR (DMSO-d, 125 MHz): δ 156.9 (C-2), 133.5 (C-3), 177.6 (C-4), 161.4 (C-5), 98.8 (C-6), 164.6 (C-7), 94.2 (C-8), 156.7 (C-9), 103.9 (C-10), 121.5 (C-1′), 131.4 (C-2′, C-6′), 116.7 (C-3′, C-5′), 157.5 (C-4′), 101.5 (C-1″), 74.3 (C-2″), 76.5 (C-3″), 70.3 (C-4″), 76.0 (C-5″), 62.2 (C-6″), 56.7 (OCH3). Kaempferol-3-O-β-D-glucopyranoside (6). Yellow amorphous powder; m.p. 176–178 °C; HRFABMS: m/z = 447.0897 (calc. for C21H19O11, 447.0927). 1H-NMR (DMSO-d, 500 MHz): δ 7.91 (2H, d, J = 8.3 Hz, H-2′, 6′), 6.86 (2H, d, J = 8.2 Hz, H-3′, 5′), 6.38 (1H, brs, H-8), 6.21 (1H, brs, H-6), 5.32 (1H, d, J = 7.5 Hz, H-1″), 3.2-4.3 (6H, sugar). 13C-NMR (DMSO-d, 125 MHz): δ 156.8 (C-2), 133.6 (C-3), 177.8 (C-4), 161.6 (C-5), 98.9 (C-6), 164.5 (C-7), 94.0 (C-8), 156.6 (C-9), 104.2 (C-10), 121.3 (C-1′), 131.0 (C-2′, C-6′), 115.5 (C-3′, C-5′), 160.0 (C-4′), 101.4 (C-1″), 74.5 (C-2″), 76.7 (C-3″), 70.1 (C-4″), 75.9 (C-5″), 62.3 (C-6″). Quercetin 3-O-β-D-glucopyranoside (7). Yellow amorphous powder; m.p. 229–231 °C; HRFABMS: m/z = 463.0758 (calc. for C21H19O12, 463.0876). 1H-NMR (DMSO-d, 500 MHz): δ 6.10 (1H, d, J = 1.9 Hz, H-6), 6.26 (1H, d, J = 1.9 Hz, H-8), 6.85 (1H, d, J = 7.5 Hz, H-5'), 7.57 (1H, dd, J = 2.0, 7.5 Hz, H-6'), 7.70 (1H, d, J = 2.0 Hz, H-2'), 5.10 (1H, d, J = 7.7 Hz, H-1''), 3.30-3.80 (6H, m, H-2'', H-3'', H-4'', H-5'', H-6''); 13C-NMR (DMSO-d, 125 MHz): δ 158.1 (C-2), 134.9 (C-3), 179.2 (C-4), 162.8 (C-5), 100.9 (C-6), 166.8 (C-7), 94.7 (C-8), 158.8 (C-9), 105.0 (C-10), 123.2 (C-1′), 116.4 (C-2′), 146.1 C-3′), 149.8 (C-4′), 117.6 (C-5′), 122.8 (C-6′) , 101.5 (C-1″), 74.5 (C-2″), 76.6 (C-3″), 70.3 (C-4″), 77.2 (C-5″), 62.1 (C-6″). Kaempferide-3-O-α-L-rhamnopyranosyl (1→6)-β-D-glucopyranoside (8). Yellow amorphous powder; m.p. 202–204 °C; HRFABMS: m/z = 607.1578 (calc. for C28H31O15, 607.1663). 1H-NMR (DMSO-d, 500 MHz): δ 7.95 (2H, d, J = 8.5 Hz, H-2′, 6′), 6.87 (2H, d, J = 8.5 Hz, H-3′, 5′), 6.44 (1H, br.s, H-8), 6.25 (1H, br.s, H-6), 5.30 (1H, d, J = 7.4 Hz, H-1″), 4.38 (1H, br.s, H-1″′), 2.9-4.5 (10H, m, sugar), 3.82 (3H, s, OCH3), 1.12 (3H, d, J = 6.2 Hz, CH3). 13C-NMR (DMSO-d, 125 MHz): δ 156.4 (C-2), 133.1 (C-3), 177.2 (C-4), 161.1 (C-5), 98.7 (C-6), 164.0 (C-7), 93.7 (C-8), 156.7 (C-9), 103.7 (C-10), 120.7 (C-1′), 131.3 (C-2′, C-6′), 116.5 (C-3′, C-5′), 158.6 (C-4′), 101.2 (C-1″), 74.0 (C-2″), 76.2 (C-3″), 69.9 (C-4″), 75.8 (C-5″), 66.7 (C-6″), 100.6 (C-1″′), 70.1 (C-2″′), 70.6 (C-3″′), 71.7 (C-4″′), 68.3 (C-5″′), 56.9 (OCH3), 17.5 (C-6″′). Kaempferol-3-O-α-L-rhamnopyranosyl (1→6)-β-D-glucopyranoside (9). Yellow amorphous powder; m.p. 219–221 °C; HRFABMS: m/z = 593.1397 (calc. for C27H29O15, 593.1506). 1H- NMR (DMSO-d, 500 MHz): δ 7.97 (2H, d, J = 8.6 Hz, H-2′, 6′), 6.89 (2H, d, J = 8.6 Hz, H-3′, 5′), 6.42 (1H, brs, H-8), 6.24 (1H, brs, H-6), 5.32 (1H, d, J = 7.6 Hz, H-1″), 4.39 (1H, brs, H-1″′), 3.0-4.4 (10H, m, sugar), 1.14 (3H, d, J = 6.5 Hz, CH3). 13C-NMR (DMSO-d, 125 MHz): δ 156.9 (C-2), 133.5 (C-3), 177.0 (C-4), 161.4 (C-5), 99.2 (C-6), 164.4 (C-7), 93.9 (C-8), 156.5 (C-9), 103.4 (C-10), 121.8 (C-1′), 130.5 (C-2′, C-6′), 115.3 (C-3′, C-5′), 160.1 (C-4′), 101.5 (C-1″), 74.3 (C-2″), 76.5 (C-3″), 70.0 (C-4″), 75.4 (C-5″), 66.5 (C-6″), 100.7 (C-1″′), 70.2 (C-2″′), 70.6 (C-3″′), 71.7 (C-4″′), 68.1 (C-5″′), 17.5 (C-6″′).

4. Conclusions

Compounds 1–9 were isolated from the first time from the aerial parts of C. sinensis and showed significant biological activities. Furthermore the purity of compounds was also checked by HPLC and the data reported here should contribute to the phytochemical inventory of the species.
  20 in total

1.  Protein glycation inhibitory and antioxidative activities of some plant extracts in vitro.

Authors:  Hye Young Kim; Kyong Kim
Journal:  J Agric Food Chem       Date:  2003-03-12       Impact factor: 5.279

Review 2.  Carrageenan-induced paw edema in the rat and mouse.

Authors:  Christopher J Morris
Journal:  Methods Mol Biol       Date:  2003

3.  A cytotoxic meroterpenoid benzoquinone from roots of Cordia globosa.

Authors:  Jane Eire Alencar de Menezes; Telma Leda Lemos; Otília Deusdênia Pessoa; Raimundo Braz-Filho; Raquel C Montenegro; Diego Veras Wilke; Letícia V Costa-Lotufo; Cláudia Pessoa; Manoel Odorico de Moraes; Edilberto R Silveira
Journal:  Planta Med       Date:  2005-01       Impact factor: 3.352

4.  Isolation and characterization of two phenolic compounds from the stem bark of Musanga cecropioides R. Brown (Moraceae).

Authors:  Buniyamin A Ayinde; Doris N Onwukaeme; Eric K Omogbai
Journal:  Acta Pol Pharm       Date:  2007 Mar-Apr       Impact factor: 0.330

5.  Studies on the homolytic and heterolytic cleavage of kaempferol and kaempferide glycosides using electrospray ionization tandem mass spectrometry.

Authors:  Lin Lu; Feng-Rui Song; Rong Tsao; Yong-Ri Jin; Zhi-Qiang Liu; Shu-Ying Liu
Journal:  Rapid Commun Mass Spectrom       Date:  2010-01       Impact factor: 2.419

6.  Antifungal and larvicidal compounds from the root bark of Cordia alliodora.

Authors:  J R Ioset; A Marston; M P Gupta; K Hostettmann
Journal:  J Nat Prod       Date:  2000-03       Impact factor: 4.050

7.  Antioxidative and anti-glycation activity of garcinol from Garcinia indica fruit rind.

Authors:  F Yamaguchi; T Ariga; Y Yoshimura; H Nakazawa
Journal:  J Agric Food Chem       Date:  2000-02       Impact factor: 5.279

8.  A quantum chemical explanation of the antioxidant activity of flavonoids.

Authors:  S A van Acker; M J de Groot; D J van den Berg; M N Tromp; G Donné-Op den Kelder; W J van der Vijgh; A Bast
Journal:  Chem Res Toxicol       Date:  1996-12       Impact factor: 3.739

9.  Determination of in vitro antioxidant and radical scavenging activities of propofol.

Authors:  Ilhami Gülçin; Haci Ahmet Alici; Mehmet Cesur
Journal:  Chem Pharm Bull (Tokyo)       Date:  2005-03       Impact factor: 1.645

10.  Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships.

Authors:  Kelly E. Heim; Anthony R. Tagliaferro; Dennis J. Bobilya
Journal:  J Nutr Biochem       Date:  2002-10       Impact factor: 6.048

View more
  17 in total

Review 1.  Plant profile, phytochemistry and pharmacology of Cordia dichotoma (Indian cherry): a review.

Authors:  Prasad G Jamkhande; Sonal R Barde; Shailesh L Patwekar; Priti S Tidke
Journal:  Asian Pac J Trop Biomed       Date:  2013-12

2.  Does quercetin and vitamin C improve exercise performance, muscle damage, and body composition in male athletes?

Authors:  Gholamreza Askari; Reza Ghiasvand; Jahangir Karimian; Awat Feizi; Zamzam Paknahad; Gholamreza Sharifirad; Maryam Hajishafiei
Journal:  J Res Med Sci       Date:  2012-04       Impact factor: 1.852

3.  Bioassay-guided isolation, identification and molecular ligand-target insight of lipoxygenase inhibitors from leaves of Anisomeles malabarica R.Br.

Authors:  A Sudha; P Srinivasan
Journal:  Pharmacogn Mag       Date:  2014-08       Impact factor: 1.085

4.  In vivo screening and evaluation of four herbs against MRSA infections.

Authors:  Najma Arshad; Arifa Mehreen; Iram Liaqat; Muhammad Arshad; Humera Afrasiab
Journal:  BMC Complement Altern Med       Date:  2017-11-23       Impact factor: 3.659

5.  In vitro inhibitory activities of selected Australian medicinal plant extracts against protein glycation, angiotensin converting enzyme (ACE) and digestive enzymes linked to type II diabetes.

Authors:  Permal Deo; Erandi Hewawasam; Aris Karakoulakis; David J Claudie; Robert Nelson; Bradley S Simpson; Nicholas M Smith; Susan J Semple
Journal:  BMC Complement Altern Med       Date:  2016-11-04       Impact factor: 3.659

6.  Evaluation of Antiulcer and Cytotoxic Potential of the Leaf, Flower, and Fruit Extracts of Calotropis procera and Isolation of a New Lignan Glycoside.

Authors:  Areej Mohammad Al-Taweel; Shagufta Perveen; Ghada Ahmed Fawzy; Attiq Ur Rehman; Afsar Khan; Rashad Mehmood; Laila Mohamed Fadda
Journal:  Evid Based Complement Alternat Med       Date:  2017-08-30       Impact factor: 2.629

Review 7.  Hydroxycinnamic Acids and Their Derivatives: Cosmeceutical Significance, Challenges and Future Perspectives, a Review.

Authors:  Oludemi Taofiq; Ana M González-Paramás; Maria Filomena Barreiro; Isabel C F R Ferreira
Journal:  Molecules       Date:  2017-02-13       Impact factor: 4.411

8.  First chemical constituents from Cordia exaltata Lam and antimicrobial activity of two neolignans.

Authors:  Tiago Bezerra de Sá de Sousa Nogueira; Raquel Bezerra de Sá de Sousa Nogueira; Davi Antas E Silva; Josean Fechine Tavares; Edeltrudes de Oliveira Lima; Fillipe de Oliveira Pereira; Jéssica Karina da Silva Maciel; Milen Maria Magalhães de Souza Fernandes; Fernando Antônio de Medeiros; Rosangela do Socorro Ferreira Rodrigues Sarquis; Raimundo Braz Filho; Maria de Fátima Vanderlei de Souza
Journal:  Molecules       Date:  2013-09-10       Impact factor: 4.411

9.  Rosmarinic Acid and Its Methyl Ester as Antimicrobial Components of the Hydromethanolic Extract of Hyptis atrorubens Poit. (Lamiaceae).

Authors:  Amin Abedini; Vincent Roumy; Séverine Mahieux; Murielle Biabiany; Annie Standaert-Vitse; Céline Rivière; Sevser Sahpaz; François Bailleul; Christel Neut; Thierry Hennebelle
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-17       Impact factor: 2.629

10.  Protective effects of oleuropein against renal injury oxidative damage in alloxan-induced diabetic rats; a histological and biochemical study.

Authors:  Hassan Ahmadvand; Gholamreza Shahsavari; Majid Tavafi; Shahrokh Bagheri; Mohamad Reza Moradkhani; Reza Mohammadrezaei Kkorramabadi; Peyman Khosravi; Maryam Jafari; Khadije Zahabi; Reza Eftekhar; Maryam Soleimaninejad; Sanaz Moghadam
Journal:  J Nephropathol       Date:  2017-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.